Abbott Laboratories (NYSE:ABT) received CE Mark for its Cologuard Plus colorectal cancer test under the EU In Vitro ...

The Cologuard Plus home screening test [Image courtesy of Abbott/Exact Sciences]Abbott (NYSE: ABT) has received approval in ...

Abbott, a global healthcare leader, announced today that the Cologuard Plus® test has received CE Mark under the European Union's In ...

Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help ...

Add Yahoo as a preferred source to see more of our stories on Google. The trial assessed SimpleScreen CRC in over 48 Abbott has commercially rolled out SimpleScreen CRC in the US, introducing a blood ...

What challenges are Greg Abbott and Gina Hinojosa facing in the final stretch of the race for Texas Governor? Here's what to know.

While colonoscopy testing remains the most reliable way to screen for colorectal cancer, SimpleScreen CRC is designed to help diagnose those who are unwilling or unable to undergo the procedure.

When Texans vote in the gubernatorial race this November, they’ll decide on who will steer how millions of the state’s ...

Abbott announced the U.S. commercial launch of SimpleScreen? CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease ...

Hinojosa has been vague about what her plans would be as governor other than to fire Greg Abbott's education commissioner, ...